Cardiomyopathy Amyotrophic lateral sclerosis Becker muscular dystrophy Lamin A/C Astrocyte Laminopathy Inflammation Myositis Thymus Satellite cell DMD Laminopathies Alternative splicing Myasthenia Gravis MG Dilated cardiomyopathy Neuromuscular disease Myoblasts Spinal muscular atrophy Neuromuscular diseases FSHD Glutamate Myopathy Genetics Autoantibodies Cytoskeleton Rare neuromuscular diseases Antisense oligonucleotides Myogenesis Myotonic Dystrophy Myotonic Dystrophy type 1 LMNA gene Exercise Biomarkers Dystrophin PABPN1 Animals Dermatomyositis Heart CMS Long read sequencing Congenital muscular dystrophy Muscular dystrophy Biomarker Motoneuron Skeletal muscle Duchenne muscular dystrophy Heart failure Nuclear envelope Myotonic dystrophy type 1 Humans LMNA OPMD Cytokines Autophagy Treatment Fibrosis MBNL Calcium Autoimmune diseases Brain Myasthenia gravis ALS Mechanotransduction Outcome measures Errance diagnostique Transcriptomics Cell therapy Dynamin 2 Aging Regeneration Congenital myopathy Aged Rare diseases Thérapie génique CTG repeat contractions RNA biology RNA interference Lamin A/C LMNA gene Centronuclear myopathy Male Genotype phenotype correlation Mice AAV Muscle regeneration Muscle Mouse model Therapy Myotonic dystrophy Autoimmunity Fabry disease Laminopathie Actin Satellite cells Transgenic mouse model Myopathies CRISPRi Gene therapy Trinucleotide repeat expansion COVID-19 Neuromuscular junction